Ovarian Endometrioid and Clear-Cell Tumors

Clear cell and endometrioid tumors are subtypes of Müllerian epithelial tumors that can arise throughout the gynecological tract, mainly including the uterus as well as the ovary. These subtypes of primary ovarian tumors include benign, borderline and malignant counterparts as opposed to other Müllerian sites where these tumors usually present as malignant neoplasms (carcinomas). A strong association with endometriosis has been established with the histogenesis of these tumors in a large subset, while in other cases, adenofibromatous lesions seem to be the primary origin of these tumors. The current chapter covers the clinicopathologic features of these endometriosis-associated histotypes of ovarian carcinoma. New updates include seromucinous carcinomas that now are a subtype of endometrioid carcinomas of the ovary as well as the likelihood that many cases of synchronous carcinomas, usually of endometrioid type, have an origin in the endometrium, determined by molecular and genetic type studies. Jennifer Katzenberg was an author in the previous edition, but has not contributed to the current edition. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others

Acs G, Pasha T, Zhang PJ (2004) WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium. Int J Gynecol Pathol 23:110–118 Ali-Fehmi R, Khalifeh I, Bandyopadhyay S et al (2006) Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis. Int J Gynecol Pathol 25:223–229 Alsop K, Fereday S, Meldrum C et al (2012) BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian ovarian cancer study group. J Clin Oncol 30:2654–2663 Amador-Ortiz C, Roma AA, Huettner PC et al (2011) JAZF1 and JJAZ1 gene fusion in primary extrauterine endometrial stromal sarcoma. Hum Pathol 42(7):939–946 Anglesio MS, Carey MS, Kobel M et al (2011) Clear cell carcinoma of the ovary: a report from the first ovarian clear cell symposium, June 24th, 2010. Gynecol Oncol 121:407–415 Anglesio MS, Bashashati A, Wang YK et al (2015) Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden. J Pathol 236:201–209 Aysal A, Karnezis A, Medhi I et al (2012) Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability. Am J Surg Pathol 36(2):163–172 Back JA, Choi MG, Ju UC et al (2016) A case of advanced-stage endometrial stromal sarcoma of the ovary arising from endometriosis. Obstet Gynecol Sci 59(4):323–327 Bell KA, Kurman RJ (2000) A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary. Am J Surg Pathol 24(11):1465–1479 Bell DA, Scully RE (1985) Benign and borderline clear cell adenofibromas of the ovary. Cancer 56:2922–2931 Bennett JA, Dong F, Young RH, Oliva E (2015) Clear cell carcinoma of the ovary: evaluation of prognostic parameters based on a clinicopathological analysis of 100 cases. Histopathology 66(6):808–815 Bennett JA, Morales-Oyarvide V, Campbell S et al (2016) Mismatch repair protein expression in clear cell carcinoma of the ovary: incidence and morphologic associations in 109 cases. Am J Surg Pathol 40(5):656–663 Berezowski K, Stastny JF, Kornstein MJ (1996) Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 9:426–429 Berton-Rigaud D, Devouassoux-Shisheboran M, Ledermann JA et al (2014) Gynecologic cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma. Int J Gynecol Cancer 24(9 Suppl 3):S55–S60 Bouchard-Fortier G, Panzarella T, Rosen B et al (2017) Endometrioid carcinoma of the ovary: outcomes compared to serous carcinoma after 10 years of follow-up. J Obstet Gynaecol Can 39(1):34–41 Cai KQ, Albarracin C, Rosen D et al (2004) Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma. Hum Pathol 35:552–559 Cao D, Guo S, Allan RW et al (2009) SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol 33:894–904 Catasús L, Bussaglia E, Rodrguez I et al (2004) Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas. Hum Pathol 35(11):1360–1368 Chang KH, Albarracin C, Luthra R et al (2006) Discordant genetic changes in ovarian and endometrial endometrioid carcinomas: a potential pitfall in molecular diagnosis. Int J Gynecol Cancer 16:178–182 Chao A, Wu RC, Jung SM et al (2016) Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology. Gynecol Oncol 143:60–67 Chen S, Leitao MM, Tornos C et al (2005) Invasion patterns in stage I endometrioid and mucinous ovarian carcinomas: a clinicopathologic analysis emphasizing favorable outcomes in carcinomas without destructive stromal invasion and the occasional malignant course of carcinomas with limited destructive stromal invasion. Mod Pathol 18(7):903–911 Cho I, Lim S-C (2016) Clear cell adenocarcinoma arising from adenofibroma in a patient with endometriosis of the ovary. J Pathol Transl Med 50(2):155–159 Cho KR, Shih IE (2009) Ovarian cancer. Annu Rev Pathol 4:287–313 Cramer DW (1987) Epidemiology of endometriosis in adolescents. In: Wilson EA (ed) Endometriosis. Alan Liss, New York, pp 5–8 De Jong RA, Nijman HW, Wilbrandi TF et al (2011) Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial component. Mol Pathol 24:1368–1379 DeLair D, Oliva E, Köbel M et al (2011) Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases. Am J Surg Pathol 35(1):36–44 Eichhorn JH, Young RH, Clement PB et al (2002) Mesodermal (müllerian) adenosarcoma of the ovary: a clinicopathologic analysis of 40 cases and a review of the literature. Am J Surg Pathol 26(10):1243–1258 Esheba GE, Pate LL, Longacre TA (2008) Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary. Am J Surg Pathol 32:600–607 Fadare O, Desouki MM, Gwin K et al (2017. Epub ahead of print) Clear cell renal cell carcinoma metastatic to the gynecologic tract: a Clinicopathologic analysis of 17 cases. Int J Gynecol Pathol 37:525 Fukunaga M, Nomura K, Ishikawa E et al (1997) Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 30:249–255 Garg G, Shah J, Kumar S et al (2010) Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes. Int J Gynecol Cancer 20:888–894 Giudice LC, Kao LC (2004) Endometriosis. Lancet 364:1789–1799 Goldstein BH, Birk CL, Van Houten M et al (2009) Ovarian cancer and late onset paraneoplastic cerebellar degeneration. Arch Gynecol Obstet 280:99–101 Gounaris I, Charnock-Jones SD, Brenton JD (2011) Ovarian clear cell carcinoma – bad endometriosis or bad endometrium? J Pathol 225:157–160 Growdon W, Roussel B, Scialabba V et al (2011) Tissue-specific signatures of activating PI3CA and RAS mutations in carcinosarcomas of gynecologic origin. Gynecol Oncol 121:212–217 Han G, Gilks CB, Leung S et al (2008) Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma. Am J Surg Pathol 32:955–964 Heidemann LN, Hartwell D, Heidemann CH et al (2014) The relation between endometriosis and ovarian cancer – a review. Acta Obstet Gynecol Scand 93:20–31 Houston DE (1984) Evidence for the risk of pelvic endometriosis by age, race, and socioeconomic status. Epidemiol Rev 6:167–191 Irving JA, Catasús L, Gallardo A et al (2005) Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis. Hum Pathol 36:605–619 Judson K, McCormick C, Vang R et al (2008) Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement. Int J Gynecol Pathol 27(2):182–190 Kanis MJ, Kolev V, Getrajdman J et al (2016) Carcinosarcoma of the ovary: a single institution experience and review of the literature. Eur J Gynaecol Oncol 37(1):75–79 Kao GF, Norris HJ (1979) Unusual cystadenofibromas: endometrioid, mucinous, and clear cell types. Obstet Gynecol 54:729–736 Kennedy AW, Biscotti CV, Hart WR et al (1989) Ovarian clear cell adenocarcinoma. Gynecol Oncol 32:342–349 Kilzieh R, Rakislova N, Torné A et al (2017 Sep) Endometrial stromal sarcoma arising in colorectal endometriosis. Int J Gynecol Pathol 36(5):433–437 Kim HS, Kim TH, Chung HH et al (2014) Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis. Br J Cancer 110:1878–1890 Klemi PJ, Meurman L, Gronroos M et al (1982) Clear cell (mesonephroid) tumors of the ovary with characteristics resembling endodermal sinus tumor. Int J Gynecol Pathol 1:95–100 Kolasa IK, Rembiszewska A, Janiec-Jankowska A et al (2006) Pten mutation, expression and loh at its locus in ovarian carcinomas. Relation to tp53, k-ras and brca1 mutations. Gynecol Oncol 103:692–697 Kuo KT, Mao TL, Jones S et al (2009) Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. Am J Pathol 174(5):1597–1601 Kurman RJ, Craig JM (1972) Endometrioid and clear cell carcinoma of the ovary. Cancer 29:1653–1664 Kurman RJ, Shih I-M (2008) Pathogenesis of ovarian cancer. Lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 27(2):151–160 Kvaskoff M, Mu F, Terry KL et al (2015) Endometriosis: a high-risk population for major chronic diseases? Hum Reprod Update 21:500–516 Lewin S, Dezube D, Guddati A et al (2012) Paraneoplastic hypercalcemia in clear cell ovarian adenocarcinoma. Ecancermedicalscience 6:271 Lewis MR, Deavers MT, Silva EG et al (2006) Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge. Am J Surg Pathol 30(2):177–184 Lu FI, Gilks CB, Mulligan AM et al (2012) Prevalence of loss of expression of DNA mismatch repair proteins in primary epithelial ovarian tumors. Int J Gynecol Pathol 31(6):524–531 Mabuchi S, Sugiyama T, Kimura T (2016) Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives. J Gynecol Oncol 27(3):e31 Matias-Guiu X, Lagarda H, Catasus L et al (2002) Clonality analysis in synchronous or metachronous tumors of the female genital tract. Int J Gynecol Pathol 21:205–211 Matsuura Y, Robertson G, Marsden DE et al (2007) Thromboembolic complications in patients with clear cell carcinoma of the ovary. Gynecol Oncol 104(2):406–410 McCluggage WG et al (2000) Benign, borderline, and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy. Int J Gynecol Pathol 19(3):276–279 Mogensen JB, Kjær SK, Mellemkjær L et al (2016) Endometriosis and risks for ovarian, endometrial and breast cancers: a nationwide cohort study. Gynecol Oncol 143(1):87–92 Nishikimi K, Kiyokawa T, Tate S et al (2015) ARID1A expression in ovarian clear cell carcinoma with an adenofibromatous component. Histopathology 67(6):866–871 Nonaka D, Chiriboga L, Soslow RA (2008) Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol 32(10):1566–1571 Offman SL, Longacre TA (2012) Clear cell carcinoma of the female genital tract (not everything is as clear as it seems). Adv Anat Pathol 19(5):296–312 Ogawa S, Kaku T, Amada S et al (2000) Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol 77:298–304 Okamoto A, Glasspool RM, Mabuchi S et al (2014) Gynecologic cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary. Int J Gynecol Cancer 24(Suppl 3):S20–S25 Oliva E, Egger JF, Young RH (2014) Primary endometrioid stromal sarcoma of the ovary: a clinicopathologic study of 27 cases with morphologic and behavioral features similar to those of uterine low-grade endometrial stromal sarcoma. Am J Surg Pathol 38(3):305–315 Palacios J, Gamallo C (1998) Mutations in the beta-catenin gene (ctnnb1) in endometrioid ovarian carcinomas. Cancer Res 58:1344–1347 Pearce CL, Templeman C, Rossing M et al (2012) Ovarian cancer association consortium. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 13:385–394 Prat J (2012 Mar) Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch 460(3):237–249 Prat J (2017) Pathology of borderline and invasive cancers. Best Pract Res Clin Obstet Gynaecol 41:15–30 Prefumo F, Venturini PL, Fulcheri E (2002) Analysis of p53 and c-erb-2 expression in ovarian endometrioid carcinomas arising in endometriosis. Int J Gynecol Pathol 22:83–88 Ramalingam P, Malpica A, Silva EG et al (2004) The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Am J Surg Pathol 28:1499–1505 Rambau PF, McIntyre JB, Taylor J et al (2017) Morphologic reproducibility, genotyping, and immunohistochemical profiling do not support a category of seromucinous carcinoma of the ovary. Am J Surg Pathol 41(5):685–695 Roma AA, Malpica A, Deavers MT (2011 Mar) Malignant melanoma arising in an ovarian carcinosarcoma: case report and review of the literature. Int J Gynecol Pathol 30(2):158–162 Roth LM, Czernobilsky B, Langley FA (1981) Ovarian endometrioid adenofibromatous and cystadenofibromatous tumors: benign, proliferating, and malignant. Cancer 48:1838–1845 Roth LM, Langley FA, Fox H et al (1984) Ovarian clear cell adenofibromatous tumors: benign, of low malignant potential, and associated with invasive clear cell carcinoma. Cancer 53:1156–1163 Sainz de la Cuesta R, Izquierdo M, Canamero M et al (2004) Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis. Eur J Obstet Gynecol Reprod Biol 15:87–93 Sampson JA (1922) Ovarian hematomas of endometrial type (perforating hemorrhagic cysts of the ovary) and implantation adenomas of endometrial type. Boston Med Surg J 186:445–473 Sangoi AR, Soslow RA, Teng NN et al (2008) Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential. Am J Surg Pathol 32(2):269–274 Sasson IE, Taylor HS (2008) Stem cells and the pathogenesis of endometriosis. Ann N Y Acad Sci 1127:106–115 Sato N, Tsunoda H, Nishida M et al (2000) Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 60:7052–7056 Schultheis AM, Ng CKY, De Fillippo MR et al (2016) Massively parallel sequencing-based clonality analysis of synchronous endometrioid endometrial and ovarian carcinomas. J Natl Cancer Inst 108:djv427 Scully RE, Young RH, Clement PB (1998) Atlas of tumor pathology. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament, Third series. Fascicle 23. Armed Forces Institute of Pathology, Washington, DC Silva EG, Young RH (2007) Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type. Am J Surg Pathol 31(8):1203–1208 Snesky TE, Liu DT (1980) Endometriosis: associations with menorrhagia, infertility, and oral contraceptives. Int J Gynaecol Obstet 17:573–576 Stewart C, Crum CP, McCluggage WG et al (2019) Guidelines to aid in the distinction of endometrial and endocervical carcinomas, and the distinction of independent primary carcinomas of the endometrium and adnexa from metastatic spread between these and other sites. Int J Gynecol Pathol 38:S75–S92 Swiersz LM (2002) Role of endometriosis in cancer and tumor development. Ann N Y Acad Sci 955:281–292 Ueda H, Watanabe Y, Nakai H et al (2005) Microsatellite status and immunohistochemical features of ovarian clear-cell carcinoma. Anticancer Res 25(4):2785–2788 Ulbright TM, Young RH (2005) Seminoma with tubular, microcystic, and related patterns: a study of 28 cases of unusual morphologic variants that often cause confusion with yolk sac tumor. Am J Surg Pathol 29(4):500–505 Uzan C, Berretta R, Rolla M et al (2012) Management and prognosis of endometrioid borderline tumors of the ovary. Surg Oncol 21(3):178–184 Valtcheva N, Lang FM, Noske A et al (2017) Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing – a case report. BMC Cancer 17(1):66 Veras E, Mao TL, Ayhan A et al (2009) Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Am J Surg Pathol 33:844–853 Vercellini P, Parazzini F, Bolis G et al (1993) Endometriosis and ovarian cancer. Am J Obstet Gynecol 169:181–182 Vierkoetter KR, Ayabe AR, VanDrunen M et al (2014) Lynch syndrome in patients with clear cell and endometrioid cancers of the ovary. Gynecol Oncol 135(1):81–84 Wei JJ, William J, Bulun S (2011) Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects. Int J Gynecol Pathol 30(6):553–568 WHO classification of Tumours editorial board (2020) Female genital tumours. WHO classification of Tumours, 5th edn. IARC Wiegand KC, Shah SP, Al-Agha OM et al (2010) ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363:1532–1543 Willis BC, Sloan EA, Atkins KA et al (2017) Mismatch repair status and PD-L1 expression in clear cell carcinomas of the ovary and endometrium. Mod Pathol 30(11):1622–1632 Willner J, Wurz K, Allison KH et al (2007) Alternate molecular genetic pathways in ovarian carcinomas of common histological types. Hum Pathol 38:607–613 Worley MJ, Welch WR, Berkowitz RS et al (2013) Endometriosis-associated ovarian cancer: a review of pathogenesis. Int J Mol Sci 14:5367–5379 Yamamoto S, Tsuda H, Yoshikawa T et al (2007) Clear cell adenocarcinoma associated with clear cell adenofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathological characteristics. Am J Surg Pathol 31:999–1006 Yamamoto S, Tsuda H, Takano M et al (2008) Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway. J Pathol 216:103–110 Yamamoto S, Tsuda H, Suzuki K et al (2009) An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway. Virchows Arch 455:261–270 Yamashita Y, Nagasaka T, Naiki-Ito A et al (2015) Napsin a is a specific marker for ovarian clear cell adenocarcinoma. Mod Pathol 28(1):111–117 Young RH, Prat J, Scully RE (1984) Endometrioid stromal sarcomas of the ovary. A clinicopathologic analysis of 23 cases. Cancer 53:1143–1155 Zhao C, Wu LS-F, Barner R (2011) Pathogenesis of ovarian clear cell Adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: Clinicopathologic features of tumors with endometriosis or Adenofibromatous components support two related pathways of tumor development. J Cancer 2:94–106 Zirker TA, Silva EG, Morris M et al (1989) Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alphafetoprotein and Leu-M1. Am J Clin Pathol 91:511–514 Conflicts of Interest and Source of Funding The authors have none to declare. Author information Authors and Affiliations Corresponding author Editor information Editors and Affiliations Rights and permissions Copyright information © 2025 Springer Nature Singapore Pte Ltd. About this entry Cite this entry Roma, A.A. (2025). Ovarian Endometrioid and Clear-Cell Tumors. In: Zheng, W., Fadare, O., Quick, C.M. (eds) Gynecologic and Obstetric Pathology. Springer, Singapore. https://doi.org/10.1007/978-981-97-4822-8_6 Download citation DOI: https://doi.org/10.1007/978-981-97-4822-8_6 Published: Publisher Name: Springer, Singapore Print ISBN: 978-981-97-4821-1 Online ISBN: 978-981-97-4822-8 eBook Packages: MedicineReference Module Medicine